市场调查报告书
商品编码
1491626
Angio Suite 市场:按类型、技术、自动化程度、应用、最终用户 - 2024-2030 年全球预测Angio Suites Market by Type (Fixed Angio Suites, Mobile Angio Suites), Technology (Computed Tomography Angiography, Digital Subtraction Angiography, Magnetic Resonance Angiography), Level of Automation, Application, End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年Angio Suites市场规模为225.7亿美元,预估2024年将达248.4亿美元,2030年将达454.5亿美元,复合年增长率为10.51%。
血管造影室或血管造影术室是专门为执行血管成像程序(称为血管造影术)而设计的设施。这些程序可以帮助医生观察身体不同部位的血管,并诊断和治疗阻塞和异常等疾病。它们通常包括 X 光成像设备和其他诊断工具,使医疗保健专业人员能够精确地查看和治疗目标区域。简而言之,血管套件对于推广治疗血管疾病的微创技术至关重要。随着冠状动脉疾病和周边动脉疾病等心血管疾病在全球的盛行率持续上升,对血管套件的需求不断增加。对配备高精度仪器的更先进的血管套件的需求日益增长,因为这些设施对于执行这些疾病通常需要的微创手术至关重要。然而,与血管摄影套件相关的高成本是公司面临的主要挑战。此外,血管摄影套件中成像技术增强功能(例如高解析度相机和即时成像软体)的市场开拓为市场成长提供了重大机会。这些进步提高了血管和介入手术的精确度和效率,增加了对配备最新技术的最先进血管套件的需求。
主要市场统计 | |
---|---|
基准年[2023] | 225.7亿美元 |
预测年份 [2024] | 248.4亿美元 |
预测年份 [2030] | 454.5亿美元 |
复合年增长率(%) | 10.51% |
区域洞察
美国市场,尤其是美国和加拿大,心血管疾病盛行率高,医疗保健支出高,导致血管治疗套件的采用率增加。该地区拥有完善的医疗基础设施,并且高度重视研究和创新,加速了先进医疗技术的采用。最近的投资重点是整合人工智慧和机器人技术,以提高血管造影术手术的准确性和效率。同时,欧洲、中东和非洲地区的医疗保健设施的现代化和扩张呈现强劲的趋势,包括更新现有的血管造影术系统。德国、法国和英国等国家因其强大的医疗保健系统和积极参与临床研究而成为该技术的主要采用者。最近的欧盟医疗设备(MDR) 法规也影响了市场动态,确保了更高的安全和品质标准。此外,亚太地区为 AngioSuites 带来了巨大的成长潜力。由于重大的医疗改革和医疗基础设施投资的增加,中国市场正在迅速扩张。日本老年人口对心血管治疗表现出持续的需求,并大力投资于技术先进的血管治疗套件。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在 Angio Suites 市场中的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一个综合工具,可以对 Angio Suites 市场中供应商的当前状态进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争力的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对 Angio Suites 市场目前地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[180 Pages Report] The Angio Suites Market size was estimated at USD 22.57 billion in 2023 and expected to reach USD 24.84 billion in 2024, at a CAGR 10.51% to reach USD 45.45 billion by 2030.
Angio suites, or angiography suites, are specialized facilities designed for performing vascular imaging procedures known as angiographies. These procedures help doctors visualize blood vessels in various parts of the body to diagnose and treat conditions such as blockages or abnormalities. The suite typically includes equipment for X-ray imaging and other diagnostic tools that help healthcare professionals view and treat the areas of interest with precision. In essence, angio suites are crucial in facilitating minimally invasive techniques for treating vascular diseases. As the prevalence of cardiovascular conditions such as coronary artery diseases and peripheral artery diseases continues to rise globally, there is an amplified demand for angio suites. These facilities are essential for performing minimally invasive surgeries that these conditions often require, thus driving the need for more advanced angio suites equipped with high-precision instruments. However, the high cost associated with the angio suites is a significant challenge faced by the companies. Moreover, the development of enhanced imaging technologies in angio suites, such as higher-resolution cameras and real-time imaging software, offers significant opportunities for market growth. These advancements improve the accuracy and efficiency of vascular and interventional procedures, thereby increasing the demand for modern angio suites equipped with the latest technology.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 22.57 billion |
Estimated Year [2024] | USD 24.84 billion |
Forecast Year [2030] | USD 45.45 billion |
CAGR (%) | 10.51% |
Regional Insights
The American market, particularly the United States and Canada, has been significant in the adoption of angio suites due to the high prevalence of cardiovascular diseases and significant healthcare spending. The region has an established healthcare infrastructure and a strong emphasis on research and innovation, accelerating the adoption of advanced medical technologies. Recent investments have focused on integrating AI and robotic technologies to enhance the precision and efficiency of angiographic procedures. At the same time, in the EMEA, there is a strong trend toward modernizing and expanding healthcare facilities, which includes updating existing angiography systems. Countries including Germany, France, and the United Kingdom are major in technology adoption due to their robust healthcare systems and active participation in clinical research. Recent EU regulations on medical devices (MDR) have also ensured higher safety and quality standards, influencing the market dynamics. Moreover, the Asia Pacific region demonstrates significant growth potential for angio suites. China's market is expanding rapidly due to large-scale healthcare reforms and increasing investment in healthcare infrastructure. Japan's older population shows sustained demand for cardiovascular procedures, thereby investing heavily in technologically advanced angio suites.
Market Insights
The market dynamics represent an ever-changing landscape of the Angio Suites Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Angio Suites Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Angio Suites Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Philips Unveils Enhanced Azurion Neuro Biplane System for Improved Neurovascular Procedures
Philips has upgraded its Azurion image-guided therapy platform by introducing the advanced Azurion neuro biplane system. This new system enhances imaging capabilities and gantry positioning flexibility, optimizing the efficiency of neurovascular interventions. According to a recent press release from the company, the Azurion neuro biplane system aims to increase patient throughput and improve clinical outcomes. [Published On: 2024-02-27]
Enhancing Cardiovascular Health through Innovative Technology Collaboration
Mentice, a player in simulation solutions, and the University Center of Excellence (Unicen) announced a strategic collaboration to advance cardiovascular healthcare technologies. This collaboration integrates Mentice's expertise in high-fidelity simulations with Unicen's clinical research capabilities. The goal is to foster innovations that enhance teaching, improve procedural outcomes, and contribute to safer clinical practices. Such a collaboration promises to accelerate the development of cutting-edge technologies in the cardiovascular field and bridge the gap between clinical research and real-world medical applications, potentially leading to better patient outcomes on a global scale. [Published On: 2024-02-21]
Canon Medical Launches Alphenix / Evolve Edition Angiography System in Europe
Canon Medical released its Alphenix / Evolve Edition angiography system for the European market, featuring real-time Deep Learning technology. This advanced system optimizes image quality and strives to reduce both the duration and radiation exposure during Percutaneous Coronary Intervention (PCI) and Structural Heart Disease (SHD) procedures. Implementing this technology promotes enhanced safety for medical professionals and patients, aiming to lead to more efficient and safer healthcare outcomes in cardiovascular treatments. [Published On: 2023-08-07]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Angio Suites Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Angio Suites Market, highlighting leading vendors and their innovative profiles. These include 3D Systems, Inc., Canon Medical Systems Corporation, Carestream Health, Carl-Zeiss-Stiftung, Center for Vascular Diseases, Covenant Health, Esaote S.p.A, FUJIFILM Holdings Corporation, GE Healthcare, Guerbet, Hitachi, Ltd., Hologic, Inc., IMRIS, Inc., Koninklijke Philips N.V., Lam Vascular & Associates, Mentice AB, Mercy Health, MIOT International, Neurotexas, PLLC, ONEX Corporation, PLANMED OY, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers, Spain Commercial, Inc., Surrey and Sussex Healthcare NHS Trust, United Biologics Inc., Universal Health Services, Inc., UTMB Health, and Vascular Surgical Associates.
Market Segmentation & Coverage